Advertisement

Eventide Healthcare & Life Sciences C ETCHX

Set alert

Price alert · ETCHX

All alert types
46.35 USD -0.46 -0.98%

At close · Oct 30

Day range unavailable

39.74 52-week range 53.97
YTD
+2.18%
1 year
+13.94%
Open
—
Prev close
46.81
Mkt cap
0
Vol
0
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
—
High
—
Forward P/E
0.00
Beta
0.00
Short ratio
0.00
Dividend
0.00
Ex-div date
50-d avg
31.75
200-d avg
31.64

2Y chart

Chart tools
Interval

Signals (87)
NameDateAgo
SMA: BullishOct 29, 20262 days ago
MACD: Buy SignalOct 21, 20261 week ago
RSI: OversoldOct 16, 20262 weeks ago
RSI: OversoldOct 13, 20262 weeks ago
SMA: BearishOct 6, 20263 weeks ago
RSI: OversoldOct 6, 20263 weeks ago
SMA: BullishOct 5, 20263 weeks ago
SMA: BearishOct 2, 20264 weeks ago
SMA: BearishSep 10, 20261 month ago
MACD: Sell SignalAug 28, 20262 months ago
RSI: OverboughtAug 19, 20262 months ago
MACD: Buy SignalAug 6, 20262 months ago
MACD: Sell SignalJul 14, 20263 months ago
RSI: OverboughtJun 25, 20264 months ago
SMA: BullishJun 18, 20264 months ago
MACD: Buy SignalJun 15, 20264 months ago
SMA: BullishJun 11, 20264 months ago
SMA: BearishJun 10, 20264 months ago
SMA: BullishJun 9, 20264 months ago
SMA: BearishJun 5, 20264 months ago
SMA: BullishJun 3, 20265 months ago
SMA: BearishJun 2, 20265 months ago
MACD: Sell SignalJun 2, 20265 months ago
SMA: BearishJun 1, 20265 months ago
MACD: Buy SignalMay 28, 20265 months ago
SMA: BullishMay 20, 20265 months ago
SMA: BearishMay 18, 20265 months ago
SMA: BullishApr 30, 20266 months ago
SMA: BearishApr 29, 20266 months ago
MACD: Sell SignalApr 27, 20266 months ago
SMA: BullishApr 7, 20266 months ago
MACD: Buy SignalMar 31, 20267 months ago
MACD: Sell SignalMar 3, 20268 months ago
SMA: BearishFeb 27, 20268 months ago
SMA: BullishFeb 24, 20268 months ago
SMA: BearishFeb 20, 20268 months ago
SMA: BullishFeb 19, 20268 months ago
MACD: Buy SignalFeb 19, 20268 months ago
SMA: BearishFeb 4, 20268 months ago
SMA: BearishJan 28, 20269 months ago
MACD: Sell SignalJan 23, 20269 months ago
MACD: Buy SignalJan 22, 20269 months ago
MACD: Sell SignalDec 9, 202510 months ago
RSI: OverboughtDec 3, 202511 months ago
RSI: OverboughtNov 17, 202511 months ago
MACD: Buy SignalNov 14, 202511 months ago
MACD: Sell SignalNov 13, 202511 months ago
MACD: Buy SignalNov 11, 202511 months ago
RSI: OverboughtNov 11, 202511 months ago
MACD: Sell SignalNov 7, 202511 months ago
MACD: Buy SignalOct 27, 20251 year ago
RSI: OverboughtOct 27, 20251 year ago
MACD: Sell SignalOct 23, 20251 year ago
RSI: OverboughtOct 20, 20251 year ago
RSI: OverboughtOct 9, 20251 year ago
MACD: Buy SignalOct 6, 20251 year ago
MACD: Sell SignalSep 12, 20251 year ago
RSI: OverboughtSep 2, 20251 year ago
RSI: OverboughtAug 27, 20251 year ago
RSI: OverboughtAug 21, 20251 year ago
RSI: OverboughtAug 12, 20251 year ago
MACD: Buy SignalAug 11, 20251 year ago
MACD: Sell SignalAug 8, 20251 year ago
MACD: Buy SignalJul 30, 20251 year ago
MACD: Sell SignalJul 21, 20251 year ago
MACD: Buy SignalJul 10, 20251 year ago
MACD: Sell SignalJun 20, 20251 year ago
RSI: OverboughtJun 10, 20251 year ago
MACD: Buy SignalMay 30, 20251 year ago
SMA: BullishMay 29, 20251 year ago
SMA: BearishMay 28, 20251 year ago
MACD: Sell SignalMay 28, 20251 year ago
SMA: BullishMay 16, 20251 year ago
SMA: BearishMay 13, 20251 year ago
SMA: BullishMay 12, 20251 year ago
SMA: BearishMay 6, 20251 year ago
SMA: BullishApr 30, 20251 year ago
MACD: Buy SignalApr 16, 20251 year ago
RSI: OversoldApr 4, 20251 year ago
RSI: OversoldApr 1, 20251 year ago
MACD: Sell SignalMar 28, 20251 year ago
MACD: Buy SignalMar 19, 20251 year ago
RSI: OversoldMar 10, 20251 year ago
SMA: BearishFeb 24, 20251 year ago
MACD: Sell SignalFeb 11, 20251 year ago
SMA: BullishJan 22, 20251 year ago
MACD: Buy SignalJan 3, 20251 year ago

Key statistics

Market cap
0
Enterprise value
0
Trailing P/E
0.00
Forward P/E
0.00
PEG ratio
0.00
Price / sales
0.00
Price / book
0.00
EPS (TTM)
0.00
Beta
0.00
Dividend yield
0.00%
Payout ratio
0.00%
Shares outstanding
0
Short % of float
0.00%
50-day average
31.75
200-day average
31.64

About Eventide Healthcare & Life Sciences C

Under normal market conditions, the fund invests at least 80% of its net assets (plus borrowings for investment purposes) in equity and equity-related securities of companies in the healthcare and life sciences sectors, including common stock, options, preferred stock and convertible debt. It may invest without limitation in securities of companies domiciled outside the United States either directly or through American Depositary Receipts ("ADRs"). The fund may invest in securities of companies of any market capitalization.

News

No recent headlines

Headlines appear here as they are published.

Your note

Sign in to keep a note on ETCHX — it syncs with the Stock Master app.

Advertisement